Devax, Inc. Completes Enrollment In The First Drug Eluting Stent Clinical Trial For A Dedicated Bifurcated Coronary Stent System
10/19/2005 5:12:04 PM
IRVINE, Calif.--(BUSINESS WIRE)--Jan. 7, 2005--Devax Inc. announced today that enrollment has been completed in the AXXESS(TM) PLUS Clinical Study for the company's AXXESS Drug Eluting Bifurcation Stent System ("AXXESS PLUS Stent System"). The trial included 138 patients from 13 international study centers between July and December 2004. Six-month angiographic follow-up is scheduled to be completed in June 2005. Professor Eberhard Grube of the Heart Center in Siegburg, Germany, is the Principle Investigator for the study.
comments powered by